Literature DB >> 9529364

Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database.

C Jeanpierre1, E Denamur, I Henry, M O Cabanis, S Luce, A Cécille, J Elion, M Peuchmaur, C Loirat, P Niaudet, M C Gubler, C Junien.   

Abstract

Constitutional mutations of the WT1 gene, encoding a zinc-finger transcription factor involved in renal and gonadal development, are found in most patients with Denys-Drash syndrome (DDS), or diffuse mesangial sclerosis (DMS) associated with pseudohermaphroditism and/or Wilms tumor (WT). Most mutations in DDS patients lie in exon 8 or exon 9, encoding zinc finger 2 or zinc finger 3, respectively, with a hot spot (R394W) in exon 9. We analyzed a series of 24 patients, 10 with isolated DMS (IDMS), 10 with DDS, and 4 with urogenital abnormalities and/or WT. We report WT1 heterozygous mutations in 16 patients, 4 of whom presented with IDMS. One male and two female IDMS patients with WT1 mutations underwent normal puberty. Two mutations associated with IDMS are different from those described in DDS patients. No WT1 mutations were detected in the six other IDMS patients, suggesting genetic heterogeneity of this disease. We analyzed genotype/phenotype correlations, on the basis of the constitution of a WT1 mutation database of 84 germ-line mutations, to compare the distribution and type of mutations, according to the different symptoms. This demonstrated (1) the association between mutations in exons 8 and 9 and DMS; (2) among patients with DMS, a higher frequency of exon 8 mutations among 46, XY patients with female phenotype than among 46,XY patients with sexual ambiguity or male phenotype; and (3) statistically significant evidence that mutations in exons 8 and 9 preferentially affect amino acids with different functions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9529364      PMCID: PMC1377045          DOI: 10.1086/301806

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  42 in total

1.  A suggested nomenclature for designating mutations.

Authors:  A L Beaudet; L C Tsui
Journal:  Hum Mutat       Date:  1993       Impact factor: 4.878

2.  DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1.

Authors:  I A Drummond; H D Rupprecht; P Rohwer-Nutter; J M Lopez-Guisa; S L Madden; F J Rauscher; V P Sukhatme
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

3.  WT-1 is required for early kidney development.

Authors:  J A Kreidberg; H Sariola; J M Loring; M Maeda; J Pelletier; D Housman; R Jaenisch
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

4.  The Wilms' tumor suppressor gene WT1 is negatively autoregulated.

Authors:  H D Rupprecht; I A Drummond; S L Madden; F J Rauscher; V P Sukhatme
Journal:  J Biol Chem       Date:  1994-02-25       Impact factor: 5.157

5.  WT1 mutations associated with incomplete Denys-Drash syndrome define a domain predicted to behave in a dominant-negative fashion.

Authors:  N Bardeesy; B Zabel; K Schmitt; J Pelletier
Journal:  Genomics       Date:  1994-06       Impact factor: 5.736

6.  Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways.

Authors:  Z Y Wang; Q Q Qiu; J Huang; M Gurrieri; T F Deuel
Journal:  Oncogene       Date:  1995-02-02       Impact factor: 9.867

7.  WT1 exon 1 deletion/insertion mutations in Wilms tumor patients, associated with di- and trinucleotide repeats and deletion hotspot consensus sequences.

Authors:  V Huff; N Jaffe; G F Saunders; L C Strong; F Villalba; E C Ruteshouser
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

8.  Mosaic and polymorphic imprinting of the WT1 gene in humans.

Authors:  Y Jinno; K Yun; K Nishiwaki; T Kubota; O Ogawa; A E Reeve; N Niikawa
Journal:  Nat Genet       Date:  1994-03       Impact factor: 38.330

9.  Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing.

Authors:  S H Larsson; J P Charlieu; K Miyagawa; D Engelkamp; M Rassoulzadegan; A Ross; F Cuzin; V van Heyningen; N D Hastie
Journal:  Cell       Date:  1995-05-05       Impact factor: 41.582

10.  DNA binding capacity of the WT1 protein is abolished by Denys-Drash syndrome WT1 point mutations.

Authors:  M Little; G Holmes; W Bickmore; V van Heyningen; N Hastie; B Wainwright
Journal:  Hum Mol Genet       Date:  1995-03       Impact factor: 6.150

View more
  72 in total

Review 1.  Frasier and Denys-Drash syndromes: different disorders or part of a spectrum?

Authors:  A Koziell; R Grundy
Journal:  Arch Dis Child       Date:  1999-10       Impact factor: 3.791

Review 2.  Educational paper: the podocytopathies.

Authors:  Anja K Büscher; Stefanie Weber
Journal:  Eur J Pediatr       Date:  2012-01-13       Impact factor: 3.183

3.  Genotype-phenotype correlations in non-Finnish congenital nephrotic syndrome.

Authors:  Eduardo Machuca; Geneviève Benoit; Fabien Nevo; Marie-Josèphe Tête; Olivier Gribouval; Audrey Pawtowski; Per Brandström; Chantal Loirat; Patrick Niaudet; Marie-Claire Gubler; Corinne Antignac
Journal:  J Am Soc Nephrol       Date:  2010-05-27       Impact factor: 10.121

Review 4.  Exploring the genetic basis of early-onset chronic kidney disease.

Authors:  Asaf Vivante; Friedhelm Hildebrandt
Journal:  Nat Rev Nephrol       Date:  2016-01-11       Impact factor: 28.314

5.  Broad and unexpected phenotypic expression in Greek children with steroid-resistant nephrotic syndrome due to mutations in the Wilms' tumor 1 (WT1) gene.

Authors:  Spyridon Megremis; Andromachi Mitsioni; Irene Fylaktou; Sofia Kitsiou Tzeli; Filadelfia Komianou; Constantinos J Stefanidis; Emmanuel Kanavakis; Joanne Traeger-Synodinos
Journal:  Eur J Pediatr       Date:  2011-04-16       Impact factor: 3.183

6.  WT1 gene mutations in three girls with nephrotic syndrome.

Authors:  Khalid Ismaili; Véronique Verdure; Katherina Vandenhoute; Françoise Janssen; Michelle Hall
Journal:  Eur J Pediatr       Date:  2007-06-01       Impact factor: 3.183

7.  GAPVD1 and ANKFY1 Mutations Implicate RAB5 Regulation in Nephrotic Syndrome.

Authors:  Tobias Hermle; Ronen Schneider; David Schapiro; Daniela A Braun; Amelie T van der Ven; Jillian K Warejko; Ankana Daga; Eugen Widmeier; Makiko Nakayama; Tilman Jobst-Schwan; Amar J Majmundar; Shazia Ashraf; Jia Rao; Laura S Finn; Velibor Tasic; Joel D Hernandez; Arvind Bagga; Sawsan M Jalalah; Sherif El Desoky; Jameela A Kari; Kristen M Laricchia; Monkol Lek; Heidi L Rehm; Daniel G MacArthur; Shrikant Mane; Richard P Lifton; Shirlee Shril; Friedhelm Hildebrandt
Journal:  J Am Soc Nephrol       Date:  2018-06-29       Impact factor: 10.121

8.  Long-term outcome of congenital nephrotic syndrome after kidney transplantation in Japan.

Authors:  Yuko Hamasaki; Masaki Muramatsu; Riku Hamada; Kenji Ishikura; Hiroshi Hataya; Hiroyuki Satou; Masataka Honda; Koichi Nakanishi; Seiichiro Shishido
Journal:  Clin Exp Nephrol       Date:  2017-11-28       Impact factor: 2.801

9.  Risk factors for end stage renal disease in non-WT1-syndromic Wilms tumor.

Authors:  Jane Lange; Susan M Peterson; Janice R Takashima; Yevgeny Grigoriev; Michael L Ritchey; Robert C Shamberger; J Bruce Beckwith; Elizabeth Perlman; Daniel M Green; Norman E Breslow
Journal:  J Urol       Date:  2011-06-17       Impact factor: 7.450

10.  The contribution of ultrasound for the differential diagnosis of congenital and infantile nephrotic syndrome.

Authors:  Hanna Salame; Nash Damry; Katt Vandenhoudt; Michèle Hall; Fred E Avni
Journal:  Eur Radiol       Date:  2003-05-08       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.